Realisation of established targets for patients with diabetes type 2 at primary care setting.

Trial Profile

Realisation of established targets for patients with diabetes type 2 at primary care setting.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Jun 2015

At a glance

  • Drugs Rosiglitazone (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Sep 2009 Additional lead trial centres identified as reported by Netherlands Trial Register.
    • 22 Sep 2009 New source identified and integrated (Netherlands Trial Register record no. NTR391).
    • 13 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top